首页> 外文OA文献 >Therapeutic potential of peripheral blood stem cell transplantation in one cirrhotic patient caused by HBV combined with HCV
【2h】

Therapeutic potential of peripheral blood stem cell transplantation in one cirrhotic patient caused by HBV combined with HCV

机译:乙肝合并丙肝引起的肝硬化患者外周血干细胞移植的治疗潜力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Stem cell based therapy was very attractive in decompensated liver cirrhosis currently. The possible mechanism might be due to its potential to help tissue regeneration with minimally invasive procedures. Here we report the case of a 44-year-old man, infected by hepatitis B virus (HBV) combined with hepatitis C virus (HCV) for longer than 10 years, who eventually developed decompensated liver cirrhosis. After being infused with mobilized peripheral blood stem cells, the patient showed significantly elevated serum albumin level, cholesterol (CHO), cholinesterase (CHE) and decreased PT (prothrombin time) during the 26 months of follow-up. To our knowledge, this is the first case of transplanting mobilized PBSCs to treat the HBV combined with HCV related decompensated liver cirrhosis.
机译:目前,基于干细胞的疗法在失代偿性肝硬化中非常有吸引力。可能的机制可能是由于其以微创程序帮助组织再生的潜力。在这里,我们报道了一名44岁的男子,他被乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染了10年以上,最终发展为代偿性肝硬化。在输注动员的外周血干细胞后,患者在随访的26个月中显示出血清白蛋白水平,胆固醇(CHO),胆碱酯酶(CHE)显着升高和PT(凝血酶原时间)降低。据我们所知,这是第一例移植动员的PBSC来治疗HBV并伴有HCV相关的代偿性肝硬化的案例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号